| Combined phenotypic assessment of cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A, N‐acetyltransferase‐2, and xanthine oxidase activities with the … S Chainuvati, AN Nafziger, JS Leeder, A Gaedigk, GL Kearns, E Sellers, ... Clinical pharmacology & therapeutics 74 (5), 437-447, 2003 | 190 | 2003 |
| Biosynthesis of the major brain gangliosides GD1a and GT1b ER Sturgill, K Aoki, PHH Lopez, D Colacurcio, K Vajn, I Lorenzini, S Majić, ... Glycobiology 22 (10), 1289-1301, 2012 | 120 | 2012 |
| Effect of a triphasic oral contraceptive on drug‐metabolizing enzyme activity as measured by the validated Cooperstown 5+ 1 cocktail T Shelepova, AN Nafziger, J Victory, ADM Kashuba, E Rowland, Y Zhang, ... The Journal of Clinical Pharmacology 45 (12), 1413-1421, 2005 | 64 | 2005 |
| Sialidase, chondroitinase ABC, and combination therapy after spinal cord contusion injury A Mountney, MR Zahner, ER Sturgill, CJ Riley, JW Aston, M Oudega, ... Journal of neurotrauma 30 (3), 181-190, 2013 | 55 | 2013 |
| Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor BD Curti, Y Koguchi, RS Leidner, AS Rolig, ER Sturgill, Z Sun, Y Wu, ... Journal for immunotherapy of cancer 9 (4), 2021 | 54 | 2021 |
| Natural killer cell evasion is essential for infection by rhesus cytomegalovirus ER Sturgill, D Malouli, SG Hansen, BJ Burwitz, S Seo, CL Schneider, ... PLoS pathogens 12 (8), e1005868, 2016 | 37 | 2016 |
| Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs JP Guo, ME Brummet, AC Myers, HJ Na, E Rowland, RL Schnaar, ... American journal of respiratory cell and molecular biology 44 (2), 238-243, 2011 | 32 | 2011 |
| Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity ER Sturgill, AS Rolig, SN Linch, C Mick, MJ Kasiewicz, Z Sun, PG Traber, ... Oncoimmunology 10 (1), 1892265, 2021 | 30 | 2021 |
| TNFR agonists: a review of current biologics targeting OX40, 4-1BB, CD27, and GITR ER Sturgill, WL Redmond AJHO 13 (11), 4-15, 2017 | 21 | 2017 |
| Combined anti-PD-1 and anti-LAG-3 checkpoint blockade enhances CD8+ TIL effector function while reducing Tregs leading to reduced immune suppression and improved overall survival E Sturgill, C Mick, D Jenkins, J Kaufmann, WL Redmond | 1 | 2018 |
| Response to anti-PD-1 and anti-LAG-3 immune checkpoint blockade is associated with induction of pro-inflammatory Tregs AS Rolig, ER Sturgill, C Mick, D Rose, J Kaufmann, N Yanamandra, ... The Journal of Immunology 208 (1_Supplement), 119.12-119.12, 2022 | | 2022 |
| Response to anti-PD-1 and anti-LAG-3 immune checkpoint blockade (ICB) is associated with induction of pro-inflammatory Tregs ER Sturgill, C Mick, JK Kaufmann, WL Redmond The Journal of Immunology 204 (1_Supplement), 91.18-91.18, 2020 | | 2020 |
| Pegzilarginase in combination with agonist anti-OX40 therapy enhances T cell priming and effector function leading to improved tumor regression and survival M Kasiewicz, A Rolig, E Sturgill, M Badeaux, S Rowlinson, WL Redmond | | 2018 |
| Galectin-3 inhibition with GR-MD-02 synergizes with agonist anti-OX40 mAb therapy leading to reduced immune suppression and improved overall survival E Sturgill, S Linch, C Mick, M Kasiewicz, W Redmond JOURNAL FOR IMMUNOTHERAPY OF CANCER 5, 2017 | | 2017 |
| Natural Killer Cell Evasion By Rhesus Cytomegalovirus ER Sturgill | | 2016 |
| Natural Killer Cell Evasion by Rhesus Cytomegalovirus: A Dissertation ER Sturgill Oregon Health & Science University, 2016 | | 2016 |
